U-Systems, a provider of automated breast ultrasound technology, has received the Health Canada approval to sell the somo v Automated Breast Ultrasound (ABUS) system as an adjunct to mammography to screen asymptomatic breast cancer women in Canada.
The approval was based on the clinical evidence that the ABUS ultrasound device aids physicians to detect breast cancer in diagnostic symptomatic and screening asymptomatic women.
The ABUS system uses proprietary technology to automate the breast ultrasound imaging process and is suited for the high-volume, screening environment.
The somo viewer Advanced 3D Workstation enables fast review and archive of patient exams, optimizing breast ultrasound screening workflow.
U-Systems president and CEO Ron Ho said with this approval from Health Canada, they are proud to make the screening tool available to improve the early detection of breast cancer in Canada.